EOFY Sale now active - 20% off Storewide! Free shipping on all orders $100+ | Australia Wide
EOFY Sale now active - 20% off Storewide! Free shipping on all orders $100+ | Australia Wide
Semax Peptide Research Australia | Nootropic Peptide Guide
| CAS number | 80714-61-0 |
|---|---|
| Sequence | Met-Glu-His-Phe-Pro-Gly-Pro (heptapeptide) |
| Classification | ACTH(4-10) analogue / neurotrophic research peptide |
| Key research areas | BDNF/NGF expression, central nervous system signalling |
| Research maturity | Long-standing Russian research history; geographically concentrated literature |
Semax Australia research centres on a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH), studied for its proposed role in neurotrophic signalling rather than the classical hormonal functions of its parent molecule. This places Semax in a distinct research category from the GH-axis, regenerative, and metabolic peptides covered elsewhere in our research range — its research interest centres on the central nervous system rather than growth hormone, tissue repair, or energy metabolism. This guide covers Semax's structure and origin, its proposed neurotrophic mechanism, its research history, and the practical handling steps for research.
Key Research Points at a Glance
- A synthetic heptapeptide (CAS 80714-61-0) derived from the ACTH(4-10) fragment, with an added Pro-Gly-Pro tripeptide extension
- Structurally related to but functionally distinct from ACTH itself — modified specifically to remove classical hormonal (corticosteroid-stimulating) activity
- Studied for its proposed influence on brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) expression
- Research origins trace to Russian neuroscience research dating back several decades, predating much of the receptor-agonist peptide research common in this catalogue
- Classified within cognitive and central nervous system research rather than the GH-axis, regenerative, or metabolic categories
- Frequently searched as "Semax peptide Australia" or "Semax nootropic research Australia" by researchers exploring neurotrophic and cognitive research
What Is Semax? Structure and Origin
Semax (CAS 80714-61-0) is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It is derived from ACTH(4-10), a fragment of the larger adrenocorticotropic hormone molecule, with an additional Pro-Gly-Pro tripeptide sequence appended to extend its stability. This modification was specifically designed to retain central nervous system activity while eliminating the classical corticosteroid-stimulating hormonal activity associated with full-length ACTH.
This origin makes Semax structurally related to ACTH but functionally distinct from it — a research peptide engineered for a specific proposed central nervous system effect rather than for the adrenal-stimulating activity of its parent hormone.
Semax ACTH(4-10) derivative structure diagram
Simple scientific diagram showing the Semax heptapeptide sequence derived from ACTH(4-10) with an added Pro-Gly-Pro extension, illustrating the structural modification from the parent hormone fragment. Minimalist line-art diagram, blue/white palette, no photorealistic elements.
Mechanism of Interest
Semax's research interest centres on its proposed influence on neurotrophic factor expression within the central nervous system, distinguishing it mechanistically from the receptor-agonist peptides that dominate growth hormone and metabolic peptide research.
BDNF and NGF Expression Research
A substantial portion of Semax research has examined its relationship with brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) expression, two signalling proteins studied for their roles in neuronal survival, plasticity, and central nervous system maintenance. Semax's proposed influence on these neurotrophic factors is the primary mechanistic basis for ongoing research interest in cognitive and neuroprotective research contexts.
Semax BDNF/NGF expression diagram
Simple diagram showing Semax's proposed influence on BDNF and NGF expression pathways within the central nervous system. Minimalist flat design, blue/white palette, no photorealistic elements.
Research History and Russian Origins
Semax was developed through Russian neuroscience research dating back to the 1980s, originating from investigations into ACTH fragments and their central nervous system activity independent of classical adrenal signalling. This research history predates much of the receptor-agonist peptide development that characterises more recently developed compounds in this catalogue, giving Semax a comparatively long-standing but geographically concentrated research base.
Distinction from Classical ACTH Activity
Full-length ACTH is studied primarily for its role in stimulating adrenal cortisol production — a classical endocrine hormonal function. Semax's structural modification specifically targets retention of central nervous system activity while minimising this adrenal-stimulating effect, which is the basis for studying it within neurotrophic and cognitive research rather than endocrine research.
Why Semax Is a Genuinely Distinct Research Category
Unlike GH-axis peptides (Ipamorelin, CJC-1295), regenerative peptides (BPC-157, TB-500), or metabolic and mitochondrial compounds (Retatrutide, MOTS-c, NAD+), Semax's research focus is the central nervous system and neurotrophic signalling specifically. It doesn't fit cleanly into any of the other categories covered across our research range, reflecting its distinct ACTH-fragment origin and CNS-focused mechanism of research interest.
Animal-Model and Cellular Research Context
Semax's research base spans both animal-model and a body of Russian clinical research history, though as with all PhaseOne products, it is supplied strictly for laboratory research purposes only, and not for any human, veterinary, therapeutic, or cosmetic application. Researchers should evaluate the original literature directly given the geographically concentrated research history of this compound.
Common Misconceptions in Semax Research Discussion
A frequent misconception is treating Semax as functionally equivalent to ACTH because of their structural relationship — Semax was specifically engineered to minimise the classical adrenal-stimulating hormonal activity of full-length ACTH while retaining proposed central nervous system effects. A second misconception is assuming Semax fits within the GH-axis or metabolic peptide categories; its research focus is distinctly neurotrophic and CNS-related.
Reconstitution, Storage and Handling
Semax ships as a lyophilised (freeze-dried) powder. Reconstitution requires bacteriostatic water — see our reconstitution guide for the process and our peptide dosage calculator for concentration calculations.
Once reconstituted, refrigerate immediately and protect from light. See our storage guide for the full set of stability variables.
Verifying Semax Purity
Every PhaseOne Semax batch is independently tested via High Performance Liquid Chromatography (HPLC) and ships with a batch-specific Certificate of Analysis. See our HPLC testing guide and research standards guide for the full process.
HPLC chromatogram example
Simplified line-chart mockup of an HPLC chromatogram: a single sharp peak on an x/y axis labelled 'retention time' and 'absorbance', clean minimalist scientific chart style, blue line on white background, no photorealistic elements.
Related Research Guides
For handling, see our reconstitution guide and storage guide . For purity standards across our range, see our research standards guide .
Sourcing Semax Peptide in Australia
Researchers searching for Semax peptide Australia suppliers should prioritise vendors who provide independent, batch-specific HPLC verification confirming identity and purity. PhaseOne supplies Semax with the same third-party testing standard applied across every product in our research range, shipped Australia-wide.
Frequently Asked Questions
What is Semax?
Semax is a synthetic heptapeptide (CAS 80714-61-0) derived from the ACTH(4-10) fragment, with an added Pro-Gly-Pro extension, studied for its proposed neurotrophic signalling effects.
Is Semax the same as ACTH?
No — Semax is structurally related to ACTH but was specifically engineered to minimise the classical adrenal-stimulating hormonal activity of full-length ACTH while retaining proposed central nervous system activity.
What is Semax's proposed mechanism?
Semax is studied for its proposed influence on brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) expression within the central nervous system.
Where did Semax research originate?
Semax was developed through Russian neuroscience research dating back to the 1980s, investigating ACTH fragments with central nervous system activity independent of adrenal signalling.
Does Semax fit into the GH-axis or metabolic peptide categories?
No — Semax's research focus is the central nervous system and neurotrophic signalling, a distinct category from GH-axis, regenerative, or metabolic peptides covered elsewhere in our research range.
How should Semax be reconstituted?
Using bacteriostatic water, following the same general process as other lyophilised research peptides, with immediate refrigeration and light protection after reconstitution.
How is Semax purity verified?
PhaseOne verifies every Semax batch via independent third-party HPLC testing with a batch-specific Certificate of Analysis.
Where can I buy Semax peptide in Australia?
PhaseOne supplies Semax for research purposes Australia-wide, with independent batch-specific HPLC testing for every product.
Disclaimer
All products supplied by PhaseOne are intended strictly for laboratory research purposes only. Products are not intended for human consumption, therapeutic use, cosmetic use, veterinary use, or diagnostic applications.
